| Code | CSB-RA076873A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
| IF | 1:50-1:200 |
| FC | 1:50-1:200 |
ATP2A2, also known as SERCA2, serves as a critical calcium-transporting ATPase responsible for maintaining calcium homeostasis within the sarcoplasmic and endoplasmic reticulum. This pump plays an essential role in muscle contraction and relaxation cycles, making it a key target for researchers investigating cardiovascular function, metabolic regulation, and calcium-dependent signaling pathways. Dysregulation of SERCA2 activity has been implicated in heart failure and various disease states, positioning it as an important focus for both basic research and therapeutic development.
This recombinant monoclonal antibody, generated against a synthetic peptide derived from human ATP2A2, offers the consistency and reproducibility that demanding experimental workflows require. As a sequence-defined reagent produced through recombinant technology, clone 20D1 eliminates the lot-to-lot variability often encountered with traditional hybridoma-derived antibodies, ensuring your results remain comparable across extended studies.
Validation across multiple detection platforms demonstrates this antibody's versatility in your research applications. Immunohistochemistry performed on paraffin-embedded human heart tissue using a Leica Bond system shows clear target detection at dilutions of 1:50 to 1:200, with citrate buffer antigen retrieval. Immunofluorescence studies in MCF7 breast cancer cells reveal distinct staining patterns, while flow cytometry analysis of HeLa cells confirms reliable detection of intracellular ATP2A2 with clear separation from isotype control.
The unconjugated format and affinity-purified preparation provide flexibility for pairing with your preferred secondary detection systems. Whether you are exploring calcium signaling mechanisms, characterizing cardiac tissue samples, or investigating SERCA2 expression in cancer cell models, this antibody delivers the performance and reliability needed for publication-quality data.
There are currently no reviews for this product.